The stock currently trades at low valuation metrics compared with its peers—a 2021 PER of 16.0x (a 37% discount to the peer mean of 25.6x) and a YE21 PBV of 2.1x (47% below the average peer PBV of 4.0x). Any share price dip resulting from its disappo...